L3VLUP
← Every manager
Free · no sign-up · Q2 2026

Which funds own CVS

CVS Health Corp in the Q2 2026 filings. At least 20 of the 91 current managers on file reported a position, worth $29.4bn between them. At least a fifth of the current managers on file hold it, which is a crowd without being the whole market. Buying and selling roughly cancelled this quarter, which is what a name looks like when the argument is still live.

Managers holding
20
at least, of 91 current
Combined value
$29.4bn
as reported
Opened
2
new this quarter
Added to
8
already held
Trimmed or sold out
11
1 sold out entirely

Only each manager’s largest 200 positions are listed here, so a smaller holder may be missing.

Managers reporting a position

Largest first. Weight is the share of that manager’s whole reported book, which is the number worth quoting: $400m is a rounding error in one book and a defining bet in another.

ManagerValueWeightSharesChange on the quarterAction
Capital World Investors
Long-only · $846bn book
$7.8bn0.9%74,951,955+$2.2bn-2,296,687Trimmed
Dodge & Cox
Value · $191bn book
$5.2bn2.7%50,012,765+$1.5bn-1,767,351Trimmed
Wellington Management Group LLP
Long-only · $580bn book
$3.5bn0.6%33,801,113+$1.9bn+11,233,381Added
Fidelity (FMR LLC)
Long-only · $2304bn book
$3.0bn0.1%28,920,617+$751m-2,276,273Trimmed
Capital Research Global Investors
Long-only · $717bn book
$2.5bn0.4%24,329,151+$1.1bn+4,316,819Added
T. Rowe Price Associates Inc
Long-only · $999bn book
$2.5bn0.3%24,203,884+$796m+420,739Added
Invesco Ltd
Long-only · $1264bn book
$2.1bn0.2%20,595,431+$325m-4,543,515Trimmed
Arrowstreet Capital LP
Quantitative · $225bn book
$524m0.2%5,069,263+$78m-1,150,493Trimmed
Glenview Capital Management LLC
Long/short equity · $5.5bn book
$499m9.1%4,824,799-$90m-3,372,000Trimmed
Janus Henderson Group Ltd
Long-only · $245bn book
$381m0.2%3,677,824+$126m+140,963Added
Viking Global Investors LP
Long/short equity · $35.1bn book
$379m1.1%3,663,361opened3,663,361New
Holocene Advisors LP
Long/short equity · $44.4bn book
$311m0.7%3,001,684-$11m-1,478,441Trimmed
AllianceBernstein LP
Long-only · $302bn book
$232m0.1%3,233,000+$19m+550,174Added
Point72 Asset Management LP
Multi-strategy · $90.7bn book
$203m0.2%1,961,032opened1,961,032New
Woodline Partners LP
Long/short equity · $32.4bn book
$112m0.3%1,083,859+$98m+889,893Added
Walleye Capital LLC
Multi-strategy · $28.0bn book
$84m0.3%813,936+$84m+813,025Added
Freestone Grove Partners LP
Multi-strategy · $15.6bn book
$52m0.3%500,910-$4.0m-276,792Trimmed
Bridgewater Associates LP
Macro · $24.4bn book
$46m0.2%440,972+$1.2m-177,456Trimmed
Harris Associates LP
Value · $75.4bn book
$35m0.0%335,817-$700k-158,309Trimmed
Davidson Kempner Capital Management LP
Long/short equity · $8.4bn book
$23m0.3%226,036+$18m+146,016Added

Sold out of this quarter

Valued at what the position was worth in the previous filing, because by this one it is gone.

Ownership through time

At least 31 of the 95 managers whose filings are on file listed CVS in Q2 2026, against 18 in Q2 2013. 1 manager fewer than in Q1 2026: 2 started positions; 3 listed it again; 2 sold out, by their own filings; 4 no longer listed it among the positions read, which can mean a holding below the listed range, a filing that reported no holdings, or a filing not yet made.

Each manager’s largest 500 positions a quarter are read, so a small holding in a very large book can be missing, and a manager is counted as leaving only where its own filing shows it.

Managers on file listing it
01836Q2 2013: 18Q3 2013: 22Q4 2013: 19Q1 2014: 1714Q2 2014: 24Q3 2014: 20Q4 2014: 23Q1 2015: 2515Q2 2015: 24Q3 2015: 29Q4 2015: 25Q1 2016: 2416Q2 2016: 34Q3 2016: 30Q4 2016: 32Q1 2017: 2917Q2 2017: 20Q3 2017: 23Q4 2017: 32Q1 2018: 3118Q2 2018: 21Q3 2018: 25Q4 2018: 33Q1 2019: 2719Q2 2019: 25Q3 2019: 25Q4 2019: 27Q1 2020: 2920Q2 2020: 26Q3 2020: 29Q4 2020: 22Q1 2021: 2821Q2 2021: 24Q3 2021: 28Q4 2021: 28Q1 2022: 2522Q2 2022: 30Q3 2022: 28Q4 2022: 30Q1 2023: 3623Q2 2023: 33Q3 2023: 33Q4 2023: 32Q1 2024: 2124Q2 2024: 24Q3 2024: 31Q4 2024: 32Q1 2025: 2925Q2 2025: 31Q3 2025: 28Q4 2025: 29Q1 2026: 3226Q2 2026: 31
  • Q2 2013: 18
  • Q3 2013: 22
  • Q4 2013: 19
  • Q1 2014: 17
  • Q2 2014: 24
  • Q3 2014: 20
  • Q4 2014: 23
  • Q1 2015: 25
  • Q2 2015: 24
  • Q3 2015: 29
  • Q4 2015: 25
  • Q1 2016: 24
  • Q2 2016: 34
  • Q3 2016: 30
  • Q4 2016: 32
  • Q1 2017: 29
  • Q2 2017: 20
  • Q3 2017: 23
  • Q4 2017: 32
  • Q1 2018: 31
  • Q2 2018: 21
  • Q3 2018: 25
  • Q4 2018: 33
  • Q1 2019: 27
  • Q2 2019: 25
  • Q3 2019: 25
  • Q4 2019: 27
  • Q1 2020: 29
  • Q2 2020: 26
  • Q3 2020: 29
  • Q4 2020: 22
  • Q1 2021: 28
  • Q2 2021: 24
  • Q3 2021: 28
  • Q4 2021: 28
  • Q1 2022: 25
  • Q2 2022: 30
  • Q3 2022: 28
  • Q4 2022: 30
  • Q1 2023: 36
  • Q2 2023: 33
  • Q3 2023: 33
  • Q4 2023: 32
  • Q1 2024: 21
  • Q2 2024: 24
  • Q3 2024: 31
  • Q4 2024: 32
  • Q1 2025: 29
  • Q2 2025: 31
  • Q3 2025: 28
  • Q4 2025: 29
  • Q1 2026: 32
  • Q2 2026: 31
Their combined reported value
$0$15bn$31bnQ2 2013: $11.9bnQ3 2013: $11.8bnQ4 2013: $14.0bnQ1 2014: $15.3bn14Q2 2014: $14.7bnQ3 2014: $15.3bnQ4 2014: $18.2bnQ1 2015: $19.7bn15Q2 2015: $20.2bnQ3 2015: $18.9bnQ4 2015: $17.8bnQ1 2016: $17.1bn16Q2 2016: $14.3bnQ3 2016: $12.8bnQ4 2016: $9.3bnQ1 2017: $8.7bn17Q2 2017: $9.0bnQ3 2017: $9.4bnQ4 2017: $10.5bnQ1 2018: $8.7bn18Q2 2018: $8.1bnQ3 2018: $10.7bnQ4 2018: $11.4bnQ1 2019: $8.5bn19Q2 2019: $8.0bnQ3 2019: $9.6bnQ4 2019: $11.4bnQ1 2020: $8.1bn20Q2 2020: $9.3bnQ3 2020: $8.9bnQ4 2020: $9.8bnQ1 2021: $10.3bn21Q2 2021: $11.8bnQ3 2021: $11.9bnQ4 2021: $14.7bnQ1 2022: $14.4bn22Q2 2022: $13.5bnQ3 2022: $13.9bnQ4 2022: $12.6bnQ1 2023: $9.6bn23Q2 2023: $9.8bnQ3 2023: $11.7bnQ4 2023: $14.2bnQ1 2024: $14.3bn24Q2 2024: $14.2bnQ3 2024: $14.2bnQ4 2024: $11.0bnQ1 2025: $19.1bn25Q2 2025: $19.6bnQ3 2025: $21.9bnQ4 2025: $22.8bnQ1 2026: $21.1bn26Q2 2026: $30.8bn
  • Q2 2013: $11.9bn
  • Q3 2013: $11.8bn
  • Q4 2013: $14.0bn
  • Q1 2014: $15.3bn
  • Q2 2014: $14.7bn
  • Q3 2014: $15.3bn
  • Q4 2014: $18.2bn
  • Q1 2015: $19.7bn
  • Q2 2015: $20.2bn
  • Q3 2015: $18.9bn
  • Q4 2015: $17.8bn
  • Q1 2016: $17.1bn
  • Q2 2016: $14.3bn
  • Q3 2016: $12.8bn
  • Q4 2016: $9.3bn
  • Q1 2017: $8.7bn
  • Q2 2017: $9.0bn
  • Q3 2017: $9.4bn
  • Q4 2017: $10.5bn
  • Q1 2018: $8.7bn
  • Q2 2018: $8.1bn
  • Q3 2018: $10.7bn
  • Q4 2018: $11.4bn
  • Q1 2019: $8.5bn
  • Q2 2019: $8.0bn
  • Q3 2019: $9.6bn
  • Q4 2019: $11.4bn
  • Q1 2020: $8.1bn
  • Q2 2020: $9.3bn
  • Q3 2020: $8.9bn
  • Q4 2020: $9.8bn
  • Q1 2021: $10.3bn
  • Q2 2021: $11.8bn
  • Q3 2021: $11.9bn
  • Q4 2021: $14.7bn
  • Q1 2022: $14.4bn
  • Q2 2022: $13.5bn
  • Q3 2022: $13.9bn
  • Q4 2022: $12.6bn
  • Q1 2023: $9.6bn
  • Q2 2023: $9.8bn
  • Q3 2023: $11.7bn
  • Q4 2023: $14.2bn
  • Q1 2024: $14.3bn
  • Q2 2024: $14.2bn
  • Q3 2024: $14.2bn
  • Q4 2024: $11.0bn
  • Q1 2025: $19.1bn
  • Q2 2025: $19.6bn
  • Q3 2025: $21.9bn
  • Q4 2025: $22.8bn
  • Q1 2026: $21.1bn
  • Q2 2026: $30.8bn

Between the quarter ends of Q1 2026 and Q2 2026. Each change in shares is valued at the Q2 2026 price, so the price’s own move is left out; a 13F shows the two quarter ends, not when in between anything was bought or sold.

Largest increases, by shares

Largest decreases, by shares

Left it

ManagerValue over timeFirst listedLargestQ2 2026
Capital World InvestorsQ2 2013$7.8bn$7.8bn
Dodge & CoxQ1 2016$5.5bn$5.2bn
Wellington Management Group LLPQ2 2013$4.2bn$3.5bn
Fidelity (FMR LLC)Q2 2013$6.1bn$3.0bn
Capital Research Global InvestorsQ2 2013$2.5bn$2.5bn
T. Rowe Price Associates IncQ2 2013$2.5bn$2.5bn
Invesco LtdQ2 2013$2.1bn$2.1bn
Arrowstreet Capital LPQ1 2017$524m$524m
Glenview Capital Management LLCQ3 2017$809m$499m
Citadel Advisors LLCQ4 2015$564m$498m
Janus Henderson Group LtdQ2 2013$399m$380m
Viking Global Investors LPQ1 2018$379m$379m
Holocene Advisors LPQ1 2018$402m$311m
AQR Capital Management LLCQ2 2013$504m$249m
AllianceBernstein LPQ2 2013$1.6bn$232m
MFS Investment ManagementQ2 2013$2.4bnlast listed Q1 2019
Two Sigma Advisers LPQ3 2015$406mlast listed Q4 2024
Marshall Wace LLPQ2 2014$383mlast listed Q1 2026
Susquehanna International Group LLPQ1 2017$306mlast listed Q1 2025
Two Sigma Investments LPQ4 2013$241mlast listed Q4 2024
Sachem Head Capital Management LPQ2 2024$237mlast listed Q4 2025
Voloridge Investment Management LLCQ1 2015$187mlast listed Q4 2024
Jane Street Group LLCQ2 2014$169mlast listed Q4 2024
Squarepoint Ops LLCQ4 2014$156mlast listed Q1 2026
Farallon Capital Management LLCQ4 2018$132mlast listed Q4 2022

What CVS is worth

Knowing who owns it is half the question. The other half is what it is worth against the companies it trades beside, which is the one an interviewer will follow up with.

Build the comp set around CVS →

How much of the picture this is

A Form 13F reports US-listed long equity and nothing else: no shorts, no bonds, no cash and no non-US listings. It arrives forty-five days after the quarter ends, so a manager who sold in July still shows the position in a filing published in August. This page reads the managers on file here rather than every filer in the market, and each manager’s largest positions rather than the whole table, so a small position in a very large book may not appear. Say “their last filing showed” rather than “they own”, and the distinction will do you credit.

What to do with a name the funds are buying

Knowing who owns something is the start of a pitch, not the pitch. The next questions are what it is worth and why they were buying.

Company names, tickers and logos are the trademarks of their respective owners and appear here to identify the company whose public figures are being used. L3VLUP is not affiliated with, sponsored by or endorsed by any company shown, and nothing here is a statement by or about that company. More

The holdings, every quarter, and the week between

One email a week on what moved in the market and what it means for the people interviewing into it, with the 13F changes the quarter they are filed.

One email a week, free, and you can leave at any point.